Physician profile
Michael Alan Kaplan
NPI 1750443289
$201,980.23
in general payments reported to CMS, 2019-2025
18 companies · $13K in 2025
The $13K reported for 2025 was more than what 97% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $103K · 2020: $8,069 · 2021: $54K · 2022: $21K · 2023: $1,950 · 2024: $766 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Food and Beverage: $5,175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,000.00 |
| Food and Beverage | $5,175.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $185,018.92 | 2019-2025 | Xpress Ent Dilation System, Latera, Audion Et Dilation System |
| Neurent Medical Limited | $12,498.27 | 2025 | Neuromark Radiofrequency Console, Neuromark System |
| Intersect Ent, INC. | $1,978.19 | 2019-2022 | |
| Medtronic, INC. | $568.54 | 2022-2025 | Propel, Sinuva |
| Glaxosmithkline, LLC. | $393.68 | 2022-2025 | Nucala |
| Optinose US, INC. | $315.33 | 2020-2025 | |
| 3-D Matrix, INC. | $286.79 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $254.42 | 2019-2025 | Dupixent |
| Genzyme Corporation | $235.07 | 2019-2025 | |
| Inspire Medical Systems, INC. | $148.90 | 2023-2025 | Inspire |
| Nalu Medical, INC. | $68.23 | 2024 | Nalu Neurostimulation System |
| Aerin Medical INC. | $62.55 | 2022-2023 | |
| Encore Medical, LP | $50.22 | 2023 | Djo Surgical |
| Acclarent, INC | $28.01 | 2020 | |
| Integra Lifesciences Corporation | $22.94 | 2025 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $22.78 | 2021 | |
| Olympus America INC. | $15.91 | 2023 | |
| Novartis Pharmaceuticals Corporation | $11.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Kaplan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.